Alpha1Health.com | Options for your New AAT Deficient Patient | Patient Brochure

Patient Kits and Brochures

ARALAST AATmosphere

Call on our team of personal advocates to support Alphas and their families at ARALAST AATmosphere.

Alpha1Health.com Survey

Take the Alpha1Health.com Survey

Take our survey to help us best meet the needs of the Alpha-1 community.

 

AATD Patient Education Kit

Patient Education Kit

The ARALAST Patient Education Kit is designed to help people living with AAT deficiency. Baxter is pleased to provide this packet of useful information about the diagnosis, treatment, and management of this condition as another service to the Alpha-1 community.

In the kit, you will find a wealth of print materials to help you with all aspects of living with Alpha-1, including these booklets:

  • Getting Started with Augmentation Therapy
  • About Alpha-1 Antitrypsin (AAT) Deficiency
  • Reimbursement Q & A
  • The ARA-ASSIST Program

Plus, the kit includes a Health Diary and a CD of relaxation music.

order kit

You or your patients may order a Patient Education Kit online or by phone at 1-866-ARALAST (272-5278).

Alpha-1 Antitrypsin (AAT) Deficiency: What it means and what you can do

Patient Brochure

This booklet is aimed at patients and families curious to learn more about AAT deficiency. This guide has information for everyone, including those considering testing, those recently diagnosed, and those just looking for more information on AAT deficiency.

The brochure covers the following topics:

  • What is AAT deficiency?
  • The screening and testing process
  • What treatment might your doctor recommend?
  • AAT augmentation with ARALAST [Alpha1-Proteinase Inhibitor (Human)]
  • Who you can contact for additional help
  • Taking charge
  • A helpful glossary of terms
Order Brochure

You may order the AATD Patient Brochure online or by phone at 1-866-ARALAST (272-5278).

You may also download a copy of the brochure.

ARALAST [Alpha1-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.

Please review the Important Safety Information and the Full Prescribing Information

adobe reader To view PDF, you will need Adobe® Acrobat® Reader® software.